1. Home
  2. PODD vs IEX Comparison

PODD vs IEX Comparison

Compare PODD & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • IEX
  • Stock Information
  • Founded
  • PODD 2000
  • IEX 1987
  • Country
  • PODD United States
  • IEX United States
  • Employees
  • PODD N/A
  • IEX N/A
  • Industry
  • PODD Medical/Dental Instruments
  • IEX Fluid Controls
  • Sector
  • PODD Health Care
  • IEX Industrials
  • Exchange
  • PODD Nasdaq
  • IEX Nasdaq
  • Market Cap
  • PODD 17.2B
  • IEX 14.0B
  • IPO Year
  • PODD 2007
  • IEX 1991
  • Fundamental
  • Price
  • PODD $257.00
  • IEX $184.66
  • Analyst Decision
  • PODD Buy
  • IEX Buy
  • Analyst Count
  • PODD 17
  • IEX 8
  • Target Price
  • PODD $302.56
  • IEX $220.14
  • AVG Volume (30 Days)
  • PODD 695.5K
  • IEX 722.4K
  • Earning Date
  • PODD 05-08-2025
  • IEX 05-01-2025
  • Dividend Yield
  • PODD N/A
  • IEX 1.49%
  • EPS Growth
  • PODD 96.55
  • IEX N/A
  • EPS
  • PODD 5.78
  • IEX 6.30
  • Revenue
  • PODD $2,071,600,000.00
  • IEX $3,282,600,000.00
  • Revenue This Year
  • PODD $20.53
  • IEX $5.42
  • Revenue Next Year
  • PODD $17.42
  • IEX $4.59
  • P/E Ratio
  • PODD $44.43
  • IEX $29.49
  • Revenue Growth
  • PODD 22.07
  • IEX 1.66
  • 52 Week Low
  • PODD $160.19
  • IEX $153.36
  • 52 Week High
  • PODD $289.46
  • IEX $238.22
  • Technical
  • Relative Strength Index (RSI)
  • PODD 50.41
  • IEX 62.38
  • Support Level
  • PODD $252.88
  • IEX $179.30
  • Resistance Level
  • PODD $260.96
  • IEX $183.28
  • Average True Range (ATR)
  • PODD 7.68
  • IEX 4.88
  • MACD
  • PODD 1.34
  • IEX 2.16
  • Stochastic Oscillator
  • PODD 65.40
  • IEX 92.99

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About IEX IDEX Corporation

Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.

Share on Social Networks: